Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
Iliès Benotmane, Aurélie Velay, Gabriela Gautier-Vargas, Jérôme Olagne, Olivier Thaunat, Samira Fafi‐Kremer, Sophie Caillard
Topics & Concepts
Neutralizing antibodyMedicineNeutralizationPharmacologyVirologyAntibodyImmunologySARS-CoV-2 and COVID-19 ResearchMisinformation and Its ImpactsCOVID-19 and Mental Health